SARS-CoV-2 Spike RBD NanobodyRecombinant Antibody [A1] (OACA12524), Unconjugated, Monoclonal

Produktübersicht

• Artikelname: SARS-CoV-2 Spike RBD NanobodyRecombinant Antibody [A1] (OACA12524), Unconjugated, Monoclonal
• Artikelnummer: ASB-OACA12524
• Hersteller Artikelnummer: OACA12524
• Alternativnummer: ASB-OACA12524-100UL
• Hersteller: Aviva
• Kategorie: Antikörper
• Applikation: ELISA, GICA, NeA
• Immunogen: Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1)
• Konjugation: Unconjugated
• Alternative Synonym: E2,GU280_gp02,Peplomer protein,spike glycoprotein,surface glycoprotein., sars-cov-2

Produkteigenschaften

• Klonalität: Monoclonal
• NCBI: 43740568
• Formulierung: Liquid

Anwendungsbeschreibung

• Application Verdünnung: Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. Binding to human ACE2 receptor and internalization of the virus into the endosomes of the host cell induces conformational changes in the Spike glycopro

Bilder

the background of antibody is clean

Activity Assay